Abstract
Transurethral resection of the prostate (TURP) is the established and standard surgical treatment for surgical procedure for lower urinary tract obstruction due to benign prostatic hyperplasia (BPH). In recent years, various technical innovations have been made, seeking surgical procedures that are technically easier to perform for urologists and less invasive to patients as we enter an aging society. We investigated the safety and efficacy of Photoselective Vaporization of the Prostate (PVP), new minimally invasive laser treatment for BPH. 97 patients underwent Photoselective Vaporization of the Prostate (PVP) using 80 W Potassium-titanyl-phosphate (KTP) laser. KTP laser vaporization was performed successfully in all 97 patients. There was minimal blood loss and none of patients need blood transfusion. No major complication occurred intraoperatively or postoperatively. Improvement in micturition status was observed immediately after PVP and was maintained over a period of 12 months. Postoperative side effect was mild, and included transient dysuria. Photoselective Vaporization of the Prostate (PVP) using 80 W KTP laser for benign prostatic hyperplasia (BPH) proved to be an effective and safe procedure for our patient including those treated with oral anticoagulants. While describing our experience and clinical results, the efficacy and the possibilities of PVP by the newest literature are discussed.
